These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7219838)

  • 1. Principles and practice of control of meningococcal disease in Norway.
    Lystad A
    NIPH Ann; 1980 Dec; 3(2):103-7. PubMed ID: 7219838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meningococcal infections-research and basis for control measures in Norway. A summarizing discussion of main topics from a symposium held on 29 April 1980 in Oslo.
    Bøvre K
    NIPH Ann; 1980 Dec; 3(2):109-25. PubMed ID: 6784040
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of meningococcal infection].
    Shaposhnikov AA
    Feldsher Akush; 1984 Mar; 49(3):11-5. PubMed ID: 6425085
    [No Abstract]   [Full Text] [Related]  

  • 4. Control of meningococcal disease: guidance for consultants in communicable disease control. PHLS Meningococcal Infections Working Group and Public Health Medicine Environmental Group.
    Commun Dis Rep CDR Rev; 1995 Dec; 5(13):R189-95. PubMed ID: 8556102
    [No Abstract]   [Full Text] [Related]  

  • 5. Guidelines for control of meningococcal disease. Laboratory Centre for Disease Control. Canadian Consensus Conference on Meningococcal Disease.
    CMAJ; 1994 Jun; 150(11):1825-39. PubMed ID: 8199959
    [No Abstract]   [Full Text] [Related]  

  • 6. Meningococcal vaccines: a neglected topic in travel medicine?
    Wilder-Smith A
    Expert Rev Vaccines; 2009 Oct; 8(10):1343-50. PubMed ID: 19803757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An epidemic of meningococcal infection at Zaria, Northern Nigeria. 3. Meningococcal carriage.
    Hassan-King M; Greenwood BM; Whittle HC; Abbott JD; Sutcliffe EM
    Trans R Soc Trop Med Hyg; 1979; 73(5):567-73. PubMed ID: 531911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meningococcal disease in Norway 1980--83.
    Bay D; Aasen S; Lystad A
    NIPH Ann; 1983 Dec; 6(2):151-3. PubMed ID: 6676680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meningococcal disease--treatment of patients and household contacts below the age of 15 years.
    Moe PJ
    NIPH Ann; 1980 Dec; 3(2):95-9. PubMed ID: 7219846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention of secondary cases of invasive meningococcal infection: role of chemoprophylaxis and vaccination].
    Chuard C; Regamey C
    Rev Med Suisse Romande; 2003 Mar; 123(3):151-4. PubMed ID: 15095699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of serogroup C meningococcal polysaccharide vaccine: results from a case-control study in Quebec.
    De Wals P; Deceuninck G; De Serres G; Boivin JF; Duval B; Remis R; Massé R
    Clin Infect Dis; 2005 Apr; 40(8):1116-22. PubMed ID: 15791510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meningococcal disease prevention and control strategies for practice-based physicians. Committee on Infectious Diseases, American Academy of Pediatrics. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.
    Pediatrics; 1996 Mar; 97(3):404-12. PubMed ID: 8604281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States.
    Shepard CW; Ortega-Sanchez IR; Scott RD; Rosenstein NE;
    Pediatrics; 2005 May; 115(5):1220-32. PubMed ID: 15867028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Only a directed prevention against meningococcal disease is justified. Inform patient's contacts about the risk of infection instead].
    Carlsson M; Franzén L; Fredriksson M; Persson O; Wärme A
    Lakartidningen; 2000 Sep; 97(37):3982-4. PubMed ID: 11036355
    [No Abstract]   [Full Text] [Related]  

  • 15. [Susceptibility to antimicrobial drugs used in the prophylaxis of meningococcal disease: situation after an epidemic wave].
    Arreaza L; de la Fuente L; Fernández S; Vázquez JA
    Rev Esp Quimioter; 2000 Jun; 13(2):182-6. PubMed ID: 10918092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meningococcal infections in a district hospital. Some clinical observations and therapeutic experiences during an epidemic in North Norway.
    Bjark P
    NIPH Ann; 1980 Dec; 3(2):83-90. PubMed ID: 7219843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the campaign on vaccination against meningococcal disease in Galicia. Methodology, advantages and disadvantages, Study of carriers].
    Malvar Pintos A
    Rev Esp Salud Publica; 1998; 72(5):393-400. PubMed ID: 9951330
    [No Abstract]   [Full Text] [Related]  

  • 18. Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for revaccination of persons at prolonged increased risk for meningococcal disease.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Sep; 58(37):1042-3. PubMed ID: 19779400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidelines for control of meningococcal disease. Bureau of Communicable Disease Epidemiology, Laboratory Centre for Disease Control, Ottawa, Ontario, Canada.
    Can Commun Dis Rep; 1994 Feb; 20(3):17-27. PubMed ID: 8167604
    [No Abstract]   [Full Text] [Related]  

  • 20. Presenting features of meningococcal disease, public health messages and media publicity: are they consistent?
    Aponso D; Bullen C
    N Z Med J; 2001 Mar; 114(1127):83-5. PubMed ID: 11297142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.